Rip1 controlled stress resistance and virulence in Mycobacterium tuberculosis
Rip1 控制结核分枝杆菌的应激抵抗力和毒力
基本信息
- 批准号:10084263
- 负责人:
- 金额:$ 46.33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-02-07 至 2024-01-31
- 项目状态:已结题
- 来源:
- 关键词:AcidsActive SitesAirAnabolismAntibioticsBacteriaChelating AgentsCleaved cellComplementCopperCountryDefectDevelopmentDiffuseDiseaseElementsEnvironmentGene Expression ProfilingGenetic EpistasisGenetic TranscriptionGrowthHomeostasisHypoxiaInfectionLinkMediatingMediator of activation proteinMembraneMetalloproteasesMetalsMolecularMorbidity - disease rateMusMycobacterium tuberculosisNOS2A geneNitric OxideOperonOxidative StressPathogenesisPathway interactionsPeptide HydrolasesPeptidesPhenotypePhosphorylationPhosphotransferasesProductionProtein-Serine-Threonine KinasesProteolysisRIPK1 geneRNARNA BindingResistanceRoleSigma FactorSignal TransductionSignaling MoleculeStressStructureSystemTestingTuberculosisVaccinesVirulenceattenuationbasebiological adaptation to stresscofactorgene repressiongenome sequencinginsightmortalitymouse modelmutantnovelpathogenpeptide synthaseprogramsresponsesensorwhole genome
项目摘要
Project Summary
The molecular basis of M. tuberculosis virulence is still incompletely understood. Within the host, M.
tuberculosis must respond to, and resist, a plethora of stresses. Recent studies using genetically defined
bacterial mutants have identified several signal transduction systems as critical to sense and respond to the
host environment, including two component systems, transmembrane serine threonine kinases, and proteolytic
systems. Rip1 is an intramembrane metalloprotease (S2P class) required for M. tuberculosis virulence in the
mouse. Intramembrane proteases are membrane bound proteases with active sites in the membrane which
cleave transmembrane substrates. Rip1 has four known substrates, the membrane spanning anti-sigma factors
for SigK,L,M and D. However, the severe virulence defect of M. tuberculosis Drip1 is not phenocopied by an M.
tuberculosis DsigKLM triple mutant or DsigD, raising the likelihood that additional downstream pathways
controlled by Rip1 are the critical mediators of virulence. We have determined that Rip1 is required for
resistance to several stresses relevant to pathogenesis, including copper, nitric oxide, and hypoxia. However,
these phenotypes are independent of the four Rip1 controlled sigma factor pathways. Genetic epistasis analysis
indicates that the copper and NO resistance pathway controlled by the Rip1 protease is independent of known
copper efflux and Cu/NO induced transcriptional systems, indicating a novel mechanism of metal/NO
resistance. Surprisingly, loss of anti-SigD (but not SigD, see above), a Rip1 substrate, causes severe copper
sensitivity, suggesting an independent signaling role for this anti-Sigma, independent of its cognate sigma. We
have isolated spontaneous mutants in the Drip1 background that suppress the Drip1 copper sensitivity
phenotype and, by counterscreening these mutants against other stresses, whole genome sequencing, and
complementation, have identified the PdtaS/PdtaR sensor kinase/response regulator pair as mediator of the
Rip1 dependent copper and NO resistance. Transcriptional profiling reveals that the Rip1/PdtaS/PdtaR system
controls, through transcriptional repression, stress induced expression of an operon encoding a nonribosomal
peptide synthase recently shown to direct synthesis of a copper chelating peptide (a chalkophore), suggesting
a plausible direct link to copper homeostasis. We also find that the virulence defect of the Drip1 strain is
substantially reversed in NOS2 deficient mice, confirming that sensitivity to nitric oxide is the a contributor to
the attenuation of the Drip1 strain. Based on these novel findings, we propose an experimental program to
dissect the molecular mechanisms by which this newly discovered M. tuberculosis Rip1/PdtaS/PdtaR signaling
cascade controls a stress response pathway that integrates cellular response to copper, nitric oxide, and
hypoxia, the contribution of chalkophore biosynthesis to this pathway, and the role of this pathway in M.
tuberculosis virulence. Characterization of this pathway through the following specific aims will yield significant
insight into M. tuberculosis host-pathogen interactions.
项目摘要
对M.结核病的毒力仍然不完全清楚。在宿主中,M。
结核病必须对过多的压力作出反应并加以抵抗。最近的研究使用基因定义的
细菌突变体已经鉴定了几种信号转导系统,它们对于感知和响应细菌的细胞周期是至关重要的。
宿主环境,包括双组分系统,跨膜丝氨酸苏氨酸激酶和蛋白水解酶,
系统. Rip 1是M.结核病毒力
老鼠.膜内蛋白酶是在膜中具有活性位点的膜结合蛋白酶,
切割跨膜底物。Rip 1有四种已知的底物,即跨膜抗σ因子
对于SigK、L、M和D。然而,M.结核分枝杆菌Drip 1不被M.
结核病DsigKLM三重突变体或DsigD,增加了额外的下游途径
Rip 1控制的蛋白质是毒力的关键介质。我们已经确定Rip 1是必需的,
对与发病机制相关的几种应激的抗性,包括铜、一氧化氮和缺氧。然而,在这方面,
这些表型独立于四种Rip 1控制的σ因子途径。遗传上位性分析
表明由Rip 1蛋白酶控制的铜和NO抗性途径不依赖于已知的
Cu外排和Cu/NO诱导的转录系统,表明金属/NO的新机制
阻力令人惊讶的是,抗SigD(但不是SigD,见上文)(Rip 1底物)的损失导致严重的铜
敏感性,这表明一个独立的信号作用,这种反西格玛,独立于其同源西格玛。我们
在Drip 1背景中分离出抑制Drip 1铜敏感性的自发突变体
表型,并通过对其他压力,全基因组测序,
互补,已经确定PdtaS/PdtaR传感器激酶/反应调节剂对作为介导的
Rip 1依赖于铜,无电阻。转录谱显示Rip 1/PdtaS/PdtaR系统
通过转录抑制控制应激诱导的编码非核糖体蛋白的操纵子的表达,
最近显示肽合酶指导铜螯合肽(chalkophore)的合成,表明
与铜稳态的直接联系我们还发现Drip 1菌株的毒力缺陷是
在NOS 2缺陷小鼠中基本上逆转,证实了对一氧化氮的敏感性是
Drip 1菌株的减毒。基于这些新的发现,我们提出了一个实验方案,
剖析了这种新发现的M.结核Rip 1/PdtaS/PdtaR信号通路
级联控制应激反应途径,整合细胞对铜,一氧化氮,
缺氧、白垩体生物合成对该途径的贡献以及该途径在M.
结核病毒力通过以下具体目标对这一途径进行表征,
对M.结核病宿主-病原体相互作用
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael Stephen Glickman其他文献
Michael Stephen Glickman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michael Stephen Glickman', 18)}}的其他基金
Rip1 controlled stress resistance and virulence in Mycobacterium tuberculosis
Rip1 控制结核分枝杆菌的应激抵抗力和毒力
- 批准号:
10547809 - 财政年份:2019
- 资助金额:
$ 46.33万 - 项目类别:
Rip1 controlled stress resistance and virulence in Mycobacterium tuberculosis
Rip1 控制结核分枝杆菌的应激抵抗力和毒力
- 批准号:
10338102 - 财政年份:2019
- 资助金额:
$ 46.33万 - 项目类别:
RP-4: Immunologic Predictors of BCG Immunotherapy for Bladder Cancer
RP-4:膀胱癌 BCG 免疫治疗的免疫预测因子
- 批准号:
10226974 - 财政年份:2018
- 资助金额:
$ 46.33万 - 项目类别:
RP-4: Immunologic Predictors of BCG Immunotherapy for Bladder Cancer
RP-4:膀胱癌 BCG 免疫治疗的免疫预测因子
- 批准号:
10453636 - 财政年份:2018
- 资助金额:
$ 46.33万 - 项目类别:
RP-4: Immunologic Predictors of BCG Immunotherapy for Bladder Cancer
RP-4:膀胱癌 BCG 免疫治疗的免疫预测因子
- 批准号:
9979823 - 财政年份:2018
- 资助金额:
$ 46.33万 - 项目类别:
Tri-Institutional TB Research Unit: Persistence and Latency
三机构结核病研究小组:持续性和潜伏期
- 批准号:
8691646 - 财政年份:2014
- 资助金额:
$ 46.33万 - 项目类别:
Tri-Institutional TB Research Unit: Persistence and Latency
三机构结核病研究单位:持续性和潜伏期
- 批准号:
9753887 - 财政年份:2014
- 资助金额:
$ 46.33万 - 项目类别:
Tri-Institutional TB Research Unit: Persistence and Latency
三机构结核病研究单位:持续性和潜伏期
- 批准号:
9081457 - 财政年份:2014
- 资助金额:
$ 46.33万 - 项目类别:
Epidemiology of SARS-CoV-2 in Low-income Countries.
低收入国家 SARS-CoV-2 的流行病学。
- 批准号:
10188735 - 财政年份:2014
- 资助金额:
$ 46.33万 - 项目类别:
相似海外基金
NSF-BSF: Towards a Molecular Understanding of Dynamic Active Sites in Advanced Alkaline Water Oxidation Catalysts
NSF-BSF:高级碱性水氧化催化剂动态活性位点的分子理解
- 批准号:
2400195 - 财政年份:2024
- 资助金额:
$ 46.33万 - 项目类别:
Standard Grant
Collaborative Research: Beyond the Single-Atom Paradigm: A Priori Design of Dual-Atom Alloy Active Sites for Efficient and Selective Chemical Conversions
合作研究:超越单原子范式:双原子合金活性位点的先验设计,用于高效和选择性化学转化
- 批准号:
2334970 - 财政年份:2024
- 资助金额:
$ 46.33万 - 项目类别:
Standard Grant
Collaborative Research: Beyond the Single-Atom Paradigm: A Priori Design of Dual-Atom Alloy Active Sites for Efficient and Selective Chemical Conversions
合作研究:超越单原子范式:双原子合金活性位点的先验设计,用于高效和选择性化学转化
- 批准号:
2334969 - 财政年份:2024
- 资助金额:
$ 46.33万 - 项目类别:
Standard Grant
Mechanochemical synthesis of nanocarbon and design of active sites for oxygen reducton/evolution reactions
纳米碳的机械化学合成和氧还原/演化反应活性位点的设计
- 批准号:
23K04919 - 财政年份:2023
- 资助金额:
$ 46.33万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Creation of porous inorganic frameworks with controlled structure of metal active sites by the building block method.
通过积木法创建具有金属活性位点受控结构的多孔无机框架。
- 批准号:
22KJ2957 - 财政年份:2023
- 资助金额:
$ 46.33万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Catalysis of Juxaposed Active Sites Created in Nanospaces and Their Applications
纳米空间中并置活性位点的催化及其应用
- 批准号:
23K04494 - 财政年份:2023
- 资助金额:
$ 46.33万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Generation of carbon active sites by modifying the oxygen containing functional groups and structures of carbons for utilizing to various catalytic reactions.
通过修饰碳的含氧官能团和结构来产生碳活性位点,用于各种催化反应。
- 批准号:
23K13831 - 财政年份:2023
- 资助金额:
$ 46.33万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
CAREER: CAS: Understanding the Chemistry of Palladium and Silyl Compounds to Design Catalyst Active Sites
职业:CAS:了解钯和甲硅烷基化合物的化学性质以设计催化剂活性位点
- 批准号:
2238379 - 财政年份:2023
- 资助金额:
$ 46.33万 - 项目类别:
Continuing Grant
CAS: Collaborative Research: Tailoring the Distribution of Transient vs. Dynamic Active Sites in Solid-Acid Catalysts and Their Impacts on Chemical Conversions
CAS:合作研究:定制固体酸催化剂中瞬时活性位点与动态活性位点的分布及其对化学转化的影响
- 批准号:
2154399 - 财政年份:2022
- 资助金额:
$ 46.33万 - 项目类别:
Standard Grant
Engineering of Active Sites in Heterogeneous Catalysts for Sustainable Chemical and Fuel Production.
用于可持续化学和燃料生产的多相催化剂活性位点工程。
- 批准号:
RGPIN-2019-06633 - 财政年份:2022
- 资助金额:
$ 46.33万 - 项目类别:
Discovery Grants Program - Individual














{{item.name}}会员




